Share-based Payment Arrangement, Expense of Turnstone Biologics Corp. from 30 Jun 2022 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Turnstone Biologics Corp. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2022 to 30 Jun 2025.
  • Turnstone Biologics Corp. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2025 was $268,000, a 74% decline year-over-year.
  • Turnstone Biologics Corp. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2025 was $2,204,000, a 48% decline year-over-year.
  • Turnstone Biologics Corp. annual Share-based Payment Arrangement, Expense for 2024 was $3,676,000, a 13% decline from 2023.
  • Turnstone Biologics Corp. annual Share-based Payment Arrangement, Expense for 2023 was $4,216,000, a 3.5% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Turnstone Biologics Corp. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,204,000 $268,000 -$751,000 -74% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $2,955,000 $325,000 -$721,000 -69% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $3,676,000 $704,000 -$382,000 -35% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $4,058,000 $907,000 -$157,000 -15% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $4,215,000 $1,019,000 -$55,000 -5.1% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $4,270,000 $1,046,000 +$54,000 +5.4% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $4,216,000 $1,086,000 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,064,000 -$124,000 -10% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $1,074,000 +$27,000 +2.6% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $992,000 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q3 2022 $1,188,000 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $1,047,000 01 Apr 2022 30 Jun 2022 10-Q 01 Sep 2023 2023 Q2

Turnstone Biologics Corp. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,676,000 -$540,000 -13% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $4,216,000 -$152,000 -3.5% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $4,368,000 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.